Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study - Concepedia

Concepedia

Publication | Open Access

Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

DOI Full Paper Access

116

Citations

24

References

2023

Year

David J. Jackson, Liam G. Heaney, Marc Humbert, Brian D. Kent, Anat Shavit, Lina Hiljemark, Lynda Olinger, David Cohen, Andrew Menzies‐Gow, Stephanie Korn,

Abstract

AstraZeneca.

References

	Year	Citations

Page 1